Boston Scientific, Inc. BSX recently obtained a CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology. When used as an element of the Vercise Genus Deep Brain Stimulation (DBS ...
Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a software update for a deep brain stimulation system intended to assist clinicians in the ...
The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...
Credit: Abbott. Liberta RC DBS is the smallest rechargeable DBS device featuring the NeuroSphere Virtual Clinical, which allows for remote programming capabilities. The Food and Drug Administration ...
The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity in ...
Abbott has received U.S. Food & Drug Administration approval to launch a deep brain stimulation system (DBS) that the company touts as the world's smallest rechargeable device of its kind, the medical ...
Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...
Medtronic plc MDT received the CE Mark for its SenSight directional lead for the treatment of system symptoms associated with movement disorders and epilepsy. SenSight is currently the only available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results